Boundless Bio gets FDA clearance for cancer drug trial
Go back to Boundless Bio gets FDA clearance for cancer drug trial| Bold Energy, Inc. (NASDAQ: BOLD) | Delayed: 2.50 +0.02 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.48 | 52 Week High | $20.74 | |||
| Open | $2.50 | 52 Week Low | $13.06 | |||
| Day High | $2.60 | P/E | N/A | |||
| Day Low | $2.45 | EPS | $0.00 | |||
| Volume | 143,903 | |||||

